350 related articles for article (PubMed ID: 19034564)
1. DNA damage response pathways in tumor suppression and cancer treatment.
Liang Y; Lin SY; Brunicardi FC; Goss J; Li K
World J Surg; 2009 Apr; 33(4):661-6. PubMed ID: 19034564
[TBL] [Abstract][Full Text] [Related]
2. Biomarker-Guided Development of DNA Repair Inhibitors.
Cleary JM; Aguirre AJ; Shapiro GI; D'Andrea AD
Mol Cell; 2020 Jun; 78(6):1070-1085. PubMed ID: 32459988
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA Damage Response in Prostate and Breast Cancer.
Wengner AM; Scholz A; Haendler B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158305
[TBL] [Abstract][Full Text] [Related]
4.
Rafiei S; Fitzpatrick K; Liu D; Cai MY; Elmarakeby HA; Park J; Ricker C; Kochupurakkal BS; Choudhury AD; Hahn WC; Balk SP; Hwang JH; Van Allen EM; Mouw KW
Cancer Res; 2020 Jun; 80(11):2094-2100. PubMed ID: 32127357
[TBL] [Abstract][Full Text] [Related]
5. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
Das S; Cardin D
Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
[TBL] [Abstract][Full Text] [Related]
6. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.
Lin SY; Rai R; Li K; Xu ZX; Elledge SJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15105-9. PubMed ID: 16217032
[TBL] [Abstract][Full Text] [Related]
7. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.
Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC
Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798
[TBL] [Abstract][Full Text] [Related]
8. Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer.
Lozano R; Castro E; Aragón IM; Cendón Y; Cattrini C; López-Casas PP; Olmos D
Br J Cancer; 2021 Feb; 124(3):552-563. PubMed ID: 33106584
[TBL] [Abstract][Full Text] [Related]
9. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
10. DNA damage response, a double-edged sword for vascular aging.
Zhang X; Zhao Q; Wang T; Long Q; Sun Y; Jiao L; Gullerova M
Ageing Res Rev; 2023 Dec; 92():102137. PubMed ID: 38007046
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation.
Muvaffak A; Coleman KG
Front Oncol; 2024; 14():1380633. PubMed ID: 38807759
[TBL] [Abstract][Full Text] [Related]
12. DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs.
Badura M; Braunstein S; Zavadil J; Schneider RJ
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18767-72. PubMed ID: 23112151
[TBL] [Abstract][Full Text] [Related]
13. Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1.
Hernández G; Ramírez MJ; Minguillón J; Quiles P; Ruiz de Garibay G; Aza-Carmona M; Bogliolo M; Pujol R; Prados-Carvajal R; Fernández J; García N; López A; Gutiérrez-Enríquez S; Diez O; Benítez J; Salinas M; Teulé A; Brunet J; Radice P; Peterlongo P; Schindler D; Huertas P; Puente XS; Lázaro C; Pujana MÀ; Surrallés J
Nat Commun; 2018 Mar; 9(1):967. PubMed ID: 29511213
[TBL] [Abstract][Full Text] [Related]
14. Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.
Brown JS; O'Carrigan B; Jackson SP; Yap TA
Cancer Discov; 2017 Jan; 7(1):20-37. PubMed ID: 28003236
[TBL] [Abstract][Full Text] [Related]
15. STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.
Zhou J; Nie RC; He ZP; Cai XX; Chen JW; Lin WP; Yin YX; Xiang ZC; Zhu TC; Xie JJ; Zhang YC; Wang X; Lin P; Xie D; D'Andrea AD; Cai MY
Adv Sci (Weinh); 2023 Dec; 10(36):e2302494. PubMed ID: 37985839
[TBL] [Abstract][Full Text] [Related]
16. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.
Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA
Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595
[TBL] [Abstract][Full Text] [Related]
17. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons.
Bright SJ; Flint DB; Martinus DKJ; Turner BX; Manandhar M; Ben Kacem M; McFadden CH; Yap TA; Shaitelman SF; Sawakuchi GO
Radiat Res; 2022 Oct; 198(4):336-346. PubMed ID: 35939823
[TBL] [Abstract][Full Text] [Related]
18. ATM controls proper mitotic spindle structure.
Palazzo L; Della Monica R; Visconti R; Costanzo V; Grieco D
Cell Cycle; 2014; 13(7):1091-100. PubMed ID: 24553124
[TBL] [Abstract][Full Text] [Related]
19. Mapping combinatorial drug effects to DNA damage response kinase inhibitors.
Zhang H; Kreis J; Schelhorn SE; Dahmen H; Grombacher T; Zühlsdorf M; Zenke FT; Guan Y
Nat Commun; 2023 Dec; 14(1):8310. PubMed ID: 38097586
[TBL] [Abstract][Full Text] [Related]
20. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
Perkhofer L; Gout J; Roger E; Kude de Almeida F; Baptista Simões C; Wiesmüller L; Seufferlein T; Kleger A
Gut; 2021 Mar; 70(3):606-617. PubMed ID: 32855305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
